L M Neckers
About
In The Last Decade
L M Neckers
24 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 940
- Oncology 672
- Immunology 523
- Cell Biology 217
- Pathology and Forensic Medicine 199
Countries citing papers authored by L M Neckers
This map shows the geographic impact of L M Neckers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L M Neckers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L M Neckers more than expected).
Fields of papers citing papers by L M Neckers
This network shows the impact of papers produced by L M Neckers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L M Neckers. The network helps show where L M Neckers may publish in the future.
Co-authorship network of co-authors of L M Neckers
This figure shows the co-authorship network connecting the top 25 collaborators of L M Neckers. A scholar is included among the top collaborators of L M Neckers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L M Neckers. L M Neckers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription. | 63 |
| 2 | Taxol induction of p21WAF1 and p53 requires c-raf-1. | 177 |
| 3 | Oligonucleotides protect cells from the cytotoxicity of several anti-cancer chemotherapeutic drugs. | 11 |
| 4 | Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences. | 12 |
| 5 | Detection of functional interferon alpha receptors in human neuroendocrine tumor cell lines using a new monoclonal antibody. | 3 |
| 6 | Benzoquinonoid ansamycins possess selective tumoricidal activity unrelated to src kinase inhibition. | 149 |
| 7 | 157 | |
| 8 | Antisense inhibition of N-myc reduces cell growth but does not affect c-myc expression in the neuroepithelioma cell line CHP100. | 3 |
| 9 | 4 | |
| 10 | Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4. | 72 |
| 11 | Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line. | 46 |
| 12 | 47 | |
| 13 | 1 | |
| 14 | 36 | |
| 15 | c-myc protein in normal tissue. Effects of fixation on its apparent subcellular distribution. | 68 |
| 16 | 2 | |
| 17 | 23 | |
| 18 | Low-grade lymphomas. Expression of developmentally regulated B-cell antigens. | 95 |
| 19 | 86 | |
| 20 | 300 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.